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ABSTRACT
Objective: To test the feasibility of using a newly devel-
oped device for laparoscopic lymphatic mapping of the
colon by simultaneous and quantitative detection of both
tissue coloration and radioactivity.
Methods: Four pigs were used in this study. In each
animal, both blue dye and radioisotope injections were
utilized. Lymphatic mapping was performed laparoscopi-
cally in the sigmoid mesocolon and in the right mesoco-
lon. A solution containing a mix of 35 microcuries of
Technetium Tc-99 sulfur Colloid and 1 mL of a vital blue
dye was administered subserosally by percutaneous inser-
tion of a 25 gauge needle under laparoscopic control. The
new device for automated sentinel-node detection con-
sists of a gamma-probe coupled with a laser device and
can be passed through a regular 10-mm trocar. The device
detects simultaneously both radioactivity and quantitative
tissue coloration. Nodes showing a radioactivity at least 5
times higher than that of the background or that had a
blue colorant concentration were considered our sentinel
nodes.
Results: Laparoscopic simultaneous and quantitative de-
tection of sentinel nodes was feasible in all pigs. One or
more sentinel nodes were identified by either the blue dye
or radioisotopic technique in both the sigmoid and right
mesocolon. Quantitative tissue coloration detection led to
the recognition of additional nodes that were not appar-
ently colored to the naked eye.
Conclusion: Laparoscopic sentinel node detection using
a device combining gamma and color detection is feasible
in the porcine model. The significance of nodes appar-
ently clear but positive with the quantitative detection
technique should be further evaluated.
Key Words: Colorectal carcinoma, Sentinel node, Lapa-
roscopic colon resection, Lymphatic mapping.
INTRODUCTION
The sentinel lymph node is the first node relay receiving
direct drainage from a primary tumor. This concept is
based on the premise that lymphatic drainage of tumors
initially occurs through dedicated lymph nodes prior to
drainage to the regional lymphatic basin. Metastatic tumor
cells progress in this way in an orderly sequential fashion
following lymphatic channels. Because the sentinel lymph
node is the first stage of metastatic nodal involvement, it is
thought that its histological status reflects the status of the
whole lymph node basin.
The sentinel lymph node concept has been validated in
studies of melanoma and breast cancer, and in these
cases, the intraoperative sentinel lymph node harvesting
of a primary melanoma or a breast cancer was found to be
an accurate staging procedure. The application of the
sentinel node concept to malignant melanoma has been
able to limit the indications of lymphadenectomy in this
pathology, thus reducing the morbidities related to it. In
breast cancer, this possibility is being explored, as well as
the possible upstaging of in situ breast cancer. However,
concerns about a fairly high false-negative rate, ranging
from 5.1% to 7.6% in a metaanalysis,1 remain. Neverthe-
less, no strong evidence exists that extended lymph node
dissection in colorectal cancer has any impact on cancer
management. Concerning gastrointestinal malignancy, the
literature remains contradictory. For several authors,2 the
sentinel node status accurately reflects the regional node
status. Nevertheless, for other authors,3 the concept of
lymphatic mapping and sentinel node identification is not
valid for colorectal cancer because a false-negative rate of
60% was observed in patients. The key methodological
factors for the assessment of sentinel nodes are the tech-
niques of detection of the nodes. Two sentinel lymph
node detection techniques are commonly used. The first
involves blue dye injection and detection of blue color in
the node. The second involves a radiotracer injection and
gamma probe detection of the node. Ideally, simultaneous
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SCIENTIFIC PAPERinjection and detection of both markers has been shown
to increase detection rates to 99%. Furthermore, reliability
and variability at different segments of the gastrointestinal
tract as well as the variability between individuals may
limit the quality of node detection. The purpose of our
study was to evaluate a new device for the detection of
sentinel nodes, applied to laparoscopic colorectal surgery,
that can simultaneously detect blue dye and radiotracer.
METHODS
An original probe was developed allowing simultaneous
detection of radiotracers and blue dye markers (Figure
1). This probe combines a standard gamma probe to a
laser probe able to identify low blue dye injected nodes.
This probe is able to perform an automatic measurement
of the color of the node as well as its radioactivity.
The dual opto-nuclear probe is designed for the preoper-
ative sentinel lymph node localization based on radiation
and tissue coloration detection (French patent N°2 823
092, USA extension N°10/119219).
This probe allows for simultaneous detection of radiotrac-
ers and blue dye concentrated in tissues. For radio detec-
tion, the probe relies on a high efficiency small-sized
CdTe semiconductor detector mounted with its close elec-
tronics at the tip of a stainless steel shaft of about 40 cm in
length and 12 mm in diameter (Figure 2). It is designed
for low to mid energy radiation detection (I-125, Tc-99m,
etc.) and operates under low bias voltage. The tip is
shielded with tungsten; an epoxy window (diameter 7 mm
x 0.3 mm) is placed in front of the detector and offers a
frontal field of view (in line with the tube).
The probe is also designed to detect the slightest quantity
of blue dye coloration in tissues. The principle on which
automatic color detection is based is the following: the
maximum of the absorption spectrum of the blue dye is
located outside the absorption range of main chro-
mophores (a chemical group that absorbs light at a spe-
cific frequency and imparts color to a molecule) present in
the tissue in this wavelength region, ie hemoglobin and
hemoglobin oxide (Figure 3). An optic fiber coupled with
a 635 nm laser diode and a photodiode are used for light
diffusion and detection in tissue, respectively. When a
minute quantity of blue dye, even invisible to the naked
eye, is absorbed by a sentinel node, the light diffusion in
this node is attenuated.
The probe is equipped with optic fibers for the detection
of attenuation of diffusion in tissues. The probe is con-
nected to the read-out module through a 3.5-m flexible
cable and operates in 2 modes: radiation detection and
optical detection. In the radiation detection mode, the
emissions from tissue gamma rays (photons) are detected
by a CdTe detector, which transforms each photon into an
electrical signal. These signals are amplified through the
preamplifier, which is located in the probe. The signals
are then transferred to the read-out module where they
are processed, counted, and displayed.
An audible alarm, proportional to the detected activity,
allows the surgeon to localize the areas of higher activity
by “sound” without requiring visual monitoring of the
display.
A foot switch connected to the system allows the start of
acquisition without touching the module. The same foot
switch is used for changing the operating mode from
radiation to optical configuration. In the optical mode,
Figure 1. Eurorad’s opto-nuclear endoscopic probe and readout
module.
Figure 2. Absorption spectra of hemoglobin, hemoglobin oxide,
and vital blue.
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out module, and similarly, an audible signal proportional
to a tissue coloration degree can be heard.
Animal Preparation
Animals were fasted overnight. On the morning of the
experiment, they were premedicated intramuscularly with
15 mg/kg of ketamine hydrogen chloride and 0.5 mg
atropine.
General anesthesia was induced with 20 mg/kg of pento-
barbital intravenously. Orotracheal intubation was done
using a 5.5-mm endotracheal tube, and anesthesia was
maintained with 2% isoflurane and air:oxygen (FiO2:0.50).
Muscle paralysis was induced with intravenous pancuro-
nium bromide (0.1 mg/kg) and saline solution adminis-
tered intravenously at 100 mL/h.
Operative Technique
Four pigs were used for the study. All pigs were operated
on by laparoscopy. Three trocars were used. The sigmoid
colon and mesocolon were exposed and studied. Then
the same method was used on the right colon a few
centimeters distal from its junction with the small bowel. A
mix of patent V blue dye (Laboratoire Guerbet, Aunay-
Sous-Bois, France) and of unfiltered 99-Tc sulfur colloid
was used. The wall of the viscera was injected subsero-
sally with a 25 gauge needle. Spillage of the mixture was
avoided by careful swabbing during injection to avoid
contamination by radioactivity or coloring at untouched
sites. Nodes were searched for in the mesocolon or the
draining lymphatic bed of the stomach. With the use of a
gamma probe, the level of radioactivity was measured in
the mesocolic fat and in all visible lymph nodes, and
gamma counts were recorded. The same probe was used
for colorimetric measurements, which were made simul-
taneously. When sentinel nodes were identified, they
were marked with a suture or a clip. At the end of the
procedure, the animals were sacrificed while still under
general anesthesia.
RESULTS
Sigmoid Colon
In 100% of cases, one or more (1 to 3) sentinel nodes were
identified after injection of the sigmoid colon. In all cases,
the sentinel nodes were identified by the blue dye tech-
nique; the radioactive technique failed to detect a sentinel
node in 3 animals.
Figure 3. The figure shows our experimental model for sentinel
node detection: laparoscopic approach (A); subserosal injection
of dye (B); detection by our newly developed probe (C).
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dye in occult sentinel nodes.
Right Colon
One or more sentinel nodes were identified in the right
mesocolon in 3 of 4 pigs. The sentinel nodes were iden-
tified by the blue dye technique directly. In 1 pig, in which
no blue nodes were initially found, the optic probe de-
tected an area of greater colorimetric activity. Dissection
of this region led to the discovery of a blue node deep in
the mesocolic fat.
DISCUSSION
In colorectal cancer, the presence of histologically cancer-
involved lymph node metastases has been shown to be an
independent prognostic indicator of survival.4 No strong
evidence exists that extended lymph node dissection in
colorectal cancer has any impact on survival or local
recurrence rates, but lymph node metastases are indica-
tors of systemic disease. It is therefore important to iden-
tify these nodes in order to accurately stage the disease
and to identify patients who may benefit from adjuvant
therapy. Studies show that this adjuvant therapy provides
survival benefits for American Joint Committee on Cancer
(AJCC) stage III patients. Unfortunately, up to 30% of
patients with negative lymph nodes (Stage II) will have a
recurrence of their disease.5 Whether it is because of
inaccurate initial staging or because of other factors of a
poor prognosis is not known. A more precise way to stage
these patients might have an impact on these numbers.
The selective analysis of sentinel nodes may offer the
possibility to do so. Studies show that both in vivo and ex
vivo techniques can lead to the detection of sentinel
nodes in cases of colon and rectal cancer.6 Moreover, the
identification of sentinel nodes by a method using either
blue dye or radioisotopes alone is less accurate than
detection performed with the combination of both meth-
ods. In melanoma and breast cancer, the detection rate is
around 80% for blue dye, 95% for radioisotopes, and 97%
to 99% with both methods.7 Therefore, the combined
gamma and laser probe may be more sensitive in the
detection of sentinel lymph nodes undetectable by the
naked eye or gamma count. Furthermore, as this new
probe is designed for laparoscopic application, and as
studies tend to validate the oncological safety of treatment
of cancer by laparoscopy,8 it might apply to in vivo lapa-
roscopic as well as ex vivo cases. The in or ex vivo
detection technique could furthermore increase the sam-
ple size that could improve the reliability of the results as
demonstrated in our study by identification of noneye-
detected sentinel nodes. In our study, 2 of 4 animals in
which sentinel lymph nodes were invisible to the naked
eye were detected through the laser probe, so-called oc-
cult sentinel lymph nodes. The automatic colorimetric
probe using laser might, in clinical cases, obviate the need
to rely solely on eye detection and may increase the
number of colored sentinel nodes that are detected, which
might in turn allow revealing more nodes involved with
tumor cells. Whether this would translate into clinical
benefits of survival for patients however remains to be
demonstrated.
For sentinel node biopsy to be clinically useful, the false-
negative rate (proportion of negative sentinel nodes in the
presence of tumoral invasion of other nodes) has to be
reduced to the lowest percentage possible. Although most
authors report sentinel node detection rates of more than
90% for colorectal cancer,2,9,10 others have reported de-
tection rates of 58% to 71%.3,11,12 For several authors,13 the
false-negative sentinel nodes have been proposed to orig-
inate from a variety of causes, such as the site and volume
of the dye or the diversion of lymph flow caused by
occlusion of lymphatic channels caused by gross tumoral
replacement of nodes. We hypothesize that technological
assistance might help to reduce these cases where a sen-
tinel node cannot be found.
Furthermore, nodes that are not located in the classical
area but in an alternate drainage area could be detected.
Some of these nodes could account for skip metastases,
which are reported in 2% to 14% of cases.11 The possibility
of using an intraoperative detection probe would increase
the capacity to detect these nodes located in alternate
pathways. In these cases, these metastases would be de-
tected, resected, and analyzed separately.
These elements could contribute to causing the search for
the sentinel lymph node in colorectal cancer to be accu-
rate as it is in melanoma or breast cancer. Our experimen-
tal model in animals and our ex vivo model on a human
being confirm the need for better training in the injection
technique allowing laparoscopic detection of sentinel
lymph node. It also illustrates the necessity to test such
new devices before regular clinical use. Merrie et al14 have
shown that the use of combined dye and the radiocolloid
injection technique and detection in colorectal cancer may
improve the quality of sentinel lymph node detection. The
simultaneous automated colorimetric and gamma probe
detection of the sentinel node may increase the detection
of the invaded nodes and may increase the correlation
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CONCLUSION
The role of sentinel lymph node detection in colorectal
malignancies remains to be established, but the integra-
tion of new devices combining radiotracer and dye detec-
tion may render sentinel lymph node harvesting more
sensitive and a more accurate predictor of lymph node
status. The prognostic significance and clinical relevance
of lymphatic mapping in patients with carcinoma of the
colon and rectum could play an important role in upstag-
ing patients and therefore increase the number of patients
who may benefit from adjuvant chemotherapy.
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